 | • レポートコード：MRC2-11QY12228 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は医療関連感染（HAI）管理のグローバル市場について調査・分析したレポートです。種類別（尿路感染症、菌血症、手術部位感染症、院内肺炎、消化管感染症、結核）市場規模、用途別（空気、水、物理的表面、皮膚消毒剤、滅菌）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別医療関連感染（HAI）管理の競争状況、市場シェア ・世界の医療関連感染（HAI）管理市場：種類別市場規模 2015年-2020年（尿路感染症、菌血症、手術部位感染症、院内肺炎、消化管感染症、結核） ・世界の医療関連感染（HAI）管理市場：種類別市場規模予測 2021年-2026年（尿路感染症、菌血症、手術部位感染症、院内肺炎、消化管感染症、結核） ・世界の医療関連感染（HAI）管理市場：用途別市場規模 2015年-2020年（空気、水、物理的表面、皮膚消毒剤、滅菌） ・世界の医療関連感染（HAI）管理市場：用途別市場規模予測 2021年-2026年（空気、水、物理的表面、皮膚消毒剤、滅菌） ・北米の医療関連感染（HAI）管理市場分析：米国、カナダ ・ヨーロッパの医療関連感染（HAI）管理市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの医療関連感染（HAI）管理市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の医療関連感染（HAI）管理市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの医療関連感染（HAI）管理市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Roche、Merck、Johnson & Johnson、Abott、Bayer、BD、Kimberly-Clark、Nordion、Cepheid ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
A hospital-acquired infection (HAI), also known as a nosocomial infection, is an infection that is acquired in a hospital or other health care facility.
The rise in the incidences of different types of hospital acquired infections, innovative technologies implemented in devices that control infection, awareness regarding the use of personalized medicines, and cost-effective drugs to treat hospital acquired infections are some of the factors that are driving the growth of this market.
Market Analysis and Insights: Global Hospital Acquired Infection Control Market
The global Hospital Acquired Infection Control market size is projected to reach US$ 1067.6 million by 2026, from US$ 1038.3 million in 2020, at a CAGR of 2.6%% during 2021-2026.
Global Hospital Acquired Infection Control Scope and Market Size
Hospital Acquired Infection Control market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hospital Acquired Infection Control market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
Roche
Merck
Johnson & Johnson
Abott
Bayer
BD
Kimberly-Clark
Nordion
Cepheid
Market segment by Type, the product can be split into
Urinary Tract Infections
Blood Stream Infections
Surgical Site Infections
Hospital Acquired Pneumonia
Gastrointestinal Infections
Tuberculosis
Market segment by Application, split into
Air
Water
Physical Surfaces
Skin disinfectants
Sterilization
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hospital Acquired Infection Control Revenue
1.4 Market by Type
1.4.1 Global Hospital Acquired Infection Control Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Urinary Tract Infections
1.4.3 Blood Stream Infections
1.4.4 Surgical Site Infections
1.4.5 Hospital Acquired Pneumonia
1.4.6 Gastrointestinal Infections
1.4.7 Tuberculosis
1.5 Market by Application
1.5.1 Global Hospital Acquired Infection Control Market Share by Application: 2020 VS 2026
1.5.2 Air
1.5.3 Water
1.5.4 Physical Surfaces
1.5.5 Skin disinfectants
1.5.6 Sterilization
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Hospital Acquired Infection Control Market Perspective (2015-2026)
2.2 Global Hospital Acquired Infection Control Growth Trends by Regions
2.2.1 Hospital Acquired Infection Control Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hospital Acquired Infection Control Historic Market Share by Regions (2015-2020)
2.2.3 Hospital Acquired Infection Control Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hospital Acquired Infection Control Market Growth Strategy
2.3.6 Primary Interviews with Key Hospital Acquired Infection Control Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Hospital Acquired Infection Control Players by Market Size
3.1.1 Global Top Hospital Acquired Infection Control Players by Revenue (2015-2020)
3.1.2 Global Hospital Acquired Infection Control Revenue Market Share by Players (2015-2020)
3.1.3 Global Hospital Acquired Infection Control Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hospital Acquired Infection Control Market Concentration Ratio
3.2.1 Global Hospital Acquired Infection Control Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hospital Acquired Infection Control Revenue in 2019
3.3 Hospital Acquired Infection Control Key Players Head office and Area Served
3.4 Key Players Hospital Acquired Infection Control Product Solution and Service
3.5 Date of Enter into Hospital Acquired Infection Control Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hospital Acquired Infection Control Historic Market Size by Type (2015-2020)
4.2 Global Hospital Acquired Infection Control Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Hospital Acquired Infection Control Market Size by Application (2015-2020)
5.2 Global Hospital Acquired Infection Control Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hospital Acquired Infection Control Market Size (2015-2020)
6.2 Hospital Acquired Infection Control Key Players in North America (2019-2020)
6.3 North America Hospital Acquired Infection Control Market Size by Type (2015-2020)
6.4 North America Hospital Acquired Infection Control Market Size by Application (2015-2020)
7 Europe
7.1 Europe Hospital Acquired Infection Control Market Size (2015-2020)
7.2 Hospital Acquired Infection Control Key Players in Europe (2019-2020)
7.3 Europe Hospital Acquired Infection Control Market Size by Type (2015-2020)
7.4 Europe Hospital Acquired Infection Control Market Size by Application (2015-2020)
8 China
8.1 China Hospital Acquired Infection Control Market Size (2015-2020)
8.2 Hospital Acquired Infection Control Key Players in China (2019-2020)
8.3 China Hospital Acquired Infection Control Market Size by Type (2015-2020)
8.4 China Hospital Acquired Infection Control Market Size by Application (2015-2020)
9 Japan
9.1 Japan Hospital Acquired Infection Control Market Size (2015-2020)
9.2 Hospital Acquired Infection Control Key Players in Japan (2019-2020)
9.3 Japan Hospital Acquired Infection Control Market Size by Type (2015-2020)
9.4 Japan Hospital Acquired Infection Control Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Hospital Acquired Infection Control Market Size (2015-2020)
10.2 Hospital Acquired Infection Control Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hospital Acquired Infection Control Market Size by Type (2015-2020)
10.4 Southeast Asia Hospital Acquired Infection Control Market Size by Application (2015-2020)
11 India
11.1 India Hospital Acquired Infection Control Market Size (2015-2020)
11.2 Hospital Acquired Infection Control Key Players in India (2019-2020)
11.3 India Hospital Acquired Infection Control Market Size by Type (2015-2020)
11.4 India Hospital Acquired Infection Control Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Hospital Acquired Infection Control Market Size (2015-2020)
12.2 Hospital Acquired Infection Control Key Players in Central & South America (2019-2020)
12.3 Central & South America Hospital Acquired Infection Control Market Size by Type (2015-2020)
12.4 Central & South America Hospital Acquired Infection Control Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Hospital Acquired Infection Control Introduction
13.1.4 Pfizer Revenue in Hospital Acquired Infection Control Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Roche
13.2.1 Roche Company Details
13.2.2 Roche Business Overview
13.2.3 Roche Hospital Acquired Infection Control Introduction
13.2.4 Roche Revenue in Hospital Acquired Infection Control Business (2015-2020)
13.2.5 Roche Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Hospital Acquired Infection Control Introduction
13.3.4 Merck Revenue in Hospital Acquired Infection Control Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Details
13.4.2 Johnson & Johnson Business Overview
13.4.3 Johnson & Johnson Hospital Acquired Infection Control Introduction
13.4.4 Johnson & Johnson Revenue in Hospital Acquired Infection Control Business (2015-2020)
13.4.5 Johnson & Johnson Recent Development
13.5 Abott
13.5.1 Abott Company Details
13.5.2 Abott Business Overview
13.5.3 Abott Hospital Acquired Infection Control Introduction
13.5.4 Abott Revenue in Hospital Acquired Infection Control Business (2015-2020)
13.5.5 Abott Recent Development
13.6 Bayer
13.6.1 Bayer Company Details
13.6.2 Bayer Business Overview
13.6.3 Bayer Hospital Acquired Infection Control Introduction
13.6.4 Bayer Revenue in Hospital Acquired Infection Control Business (2015-2020)
13.6.5 Bayer Recent Development
13.7 BD
13.7.1 BD Company Details
13.7.2 BD Business Overview
13.7.3 BD Hospital Acquired Infection Control Introduction
13.7.4 BD Revenue in Hospital Acquired Infection Control Business (2015-2020)
13.7.5 BD Recent Development
13.8 Kimberly-Clark
13.8.1 Kimberly-Clark Company Details
13.8.2 Kimberly-Clark Business Overview
13.8.3 Kimberly-Clark Hospital Acquired Infection Control Introduction
13.8.4 Kimberly-Clark Revenue in Hospital Acquired Infection Control Business (2015-2020)
13.8.5 Kimberly-Clark Recent Development
13.9 Nordion
13.9.1 Nordion Company Details
13.9.2 Nordion Business Overview
13.9.3 Nordion Hospital Acquired Infection Control Introduction
13.9.4 Nordion Revenue in Hospital Acquired Infection Control Business (2015-2020)
13.9.5 Nordion Recent Development
13.10 Cepheid
13.10.1 Cepheid Company Details
13.10.2 Cepheid Business Overview
13.10.3 Cepheid Hospital Acquired Infection Control Introduction
13.10.4 Cepheid Revenue in Hospital Acquired Infection Control Business (2015-2020)
13.10.5 Cepheid Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Hospital Acquired Infection Control Key Market Segments
Table 2. Key Players Covered: Ranking by Hospital Acquired Infection Control Revenue
Table 3. Ranking of Global Top Hospital Acquired Infection Control Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hospital Acquired Infection Control Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Urinary Tract Infections
Table 6. Key Players of Blood Stream Infections
Table 7. Key Players of Surgical Site Infections
Table 8. Key Players of Hospital Acquired Pneumonia
Table 9. Key Players of Gastrointestinal Infections
Table 10. Key Players of Tuberculosis
Table 11. Global Hospital Acquired Infection Control Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Hospital Acquired Infection Control Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Hospital Acquired Infection Control Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Hospital Acquired Infection Control Market Share by Regions (2015-2020)
Table 15. Global Hospital Acquired Infection Control Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Hospital Acquired Infection Control Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Hospital Acquired Infection Control Market Growth Strategy
Table 21. Main Points Interviewed from Key Hospital Acquired Infection Control Players
Table 22. Global Hospital Acquired Infection Control Revenue by Players (2015-2020) (Million US$)
Table 23. Global Hospital Acquired Infection Control Market Share by Players (2015-2020)
Table 24. Global Top Hospital Acquired Infection Control Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital Acquired Infection Control as of 2019)
Table 25. Global Hospital Acquired Infection Control by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Hospital Acquired Infection Control Product Solution and Service
Table 28. Date of Enter into Hospital Acquired Infection Control Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Hospital Acquired Infection Control Market Size by Type (2015-2020) (Million US$)
Table 31. Global Hospital Acquired Infection Control Market Size Share by Type (2015-2020)
Table 32. Global Hospital Acquired Infection Control Revenue Market Share by Type (2021-2026)
Table 33. Global Hospital Acquired Infection Control Market Size Share by Application (2015-2020)
Table 34. Global Hospital Acquired Infection Control Market Size by Application (2015-2020) (Million US$)
Table 35. Global Hospital Acquired Infection Control Market Size Share by Application (2021-2026)
Table 36. North America Key Players Hospital Acquired Infection Control Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Hospital Acquired Infection Control Market Share (2019-2020)
Table 38. North America Hospital Acquired Infection Control Market Size by Type (2015-2020) (Million US$)
Table 39. North America Hospital Acquired Infection Control Market Share by Type (2015-2020)
Table 40. North America Hospital Acquired Infection Control Market Size by Application (2015-2020) (Million US$)
Table 41. North America Hospital Acquired Infection Control Market Share by Application (2015-2020)
Table 42. Europe Key Players Hospital Acquired Infection Control Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Hospital Acquired Infection Control Market Share (2019-2020)
Table 44. Europe Hospital Acquired Infection Control Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Hospital Acquired Infection Control Market Share by Type (2015-2020)
Table 46. Europe Hospital Acquired Infection Control Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Hospital Acquired Infection Control Market Share by Application (2015-2020)
Table 48. China Key Players Hospital Acquired Infection Control Revenue (2019-2020) (Million US$)
Table 49. China Key Players Hospital Acquired Infection Control Market Share (2019-2020)
Table 50. China Hospital Acquired Infection Control Market Size by Type (2015-2020) (Million US$)
Table 51. China Hospital Acquired Infection Control Market Share by Type (2015-2020)
Table 52. China Hospital Acquired Infection Control Market Size by Application (2015-2020) (Million US$)
Table 53. China Hospital Acquired Infection Control Market Share by Application (2015-2020)
Table 54. Japan Key Players Hospital Acquired Infection Control Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Hospital Acquired Infection Control Market Share (2019-2020)
Table 56. Japan Hospital Acquired Infection Control Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Hospital Acquired Infection Control Market Share by Type (2015-2020)
Table 58. Japan Hospital Acquired Infection Control Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Hospital Acquired Infection Control Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Hospital Acquired Infection Control Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Hospital Acquired Infection Control Market Share (2019-2020)
Table 62. Southeast Asia Hospital Acquired Infection Control Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Hospital Acquired Infection Control Market Share by Type (2015-2020)
Table 64. Southeast Asia Hospital Acquired Infection Control Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Hospital Acquired Infection Control Market Share by Application (2015-2020)
Table 66. India Key Players Hospital Acquired Infection Control Revenue (2019-2020) (Million US$)
Table 67. India Key Players Hospital Acquired Infection Control Market Share (2019-2020)
Table 68. India Hospital Acquired Infection Control Market Size by Type (2015-2020) (Million US$)
Table 69. India Hospital Acquired Infection Control Market Share by Type (2015-2020)
Table 70. India Hospital Acquired Infection Control Market Size by Application (2015-2020) (Million US$)
Table 71. India Hospital Acquired Infection Control Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Hospital Acquired Infection Control Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Hospital Acquired Infection Control Market Share (2019-2020)
Table 74. Central & South America Hospital Acquired Infection Control Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Hospital Acquired Infection Control Market Share by Type (2015-2020)
Table 76. Central & South America Hospital Acquired Infection Control Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Hospital Acquired Infection Control Market Share by Application (2015-2020)
Table 78. Pfizer Company Details
Table 79. Pfizer Business Overview
Table 80. Pfizer Product
Table 81. Pfizer Revenue in Hospital Acquired Infection Control Business (2015-2020) (Million US$)
Table 82. Pfizer Recent Development
Table 83. Roche Company Details
Table 84. Roche Business Overview
Table 85. Roche Product
Table 86. Roche Revenue in Hospital Acquired Infection Control Business (2015-2020) (Million US$)
Table 87. Roche Recent Development
Table 88. Merck Company Details
Table 89. Merck Business Overview
Table 90. Merck Product
Table 91. Merck Revenue in Hospital Acquired Infection Control Business (2015-2020) (Million US$)
Table 92. Merck Recent Development
Table 93. Johnson & Johnson Company Details
Table 94. Johnson & Johnson Business Overview
Table 95. Johnson & Johnson Product
Table 96. Johnson & Johnson Revenue in Hospital Acquired Infection Control Business (2015-2020) (Million US$)
Table 97. Johnson & Johnson Recent Development
Table 98. Abott Company Details
Table 99. Abott Business Overview
Table 100. Abott Product
Table 101. Abott Revenue in Hospital Acquired Infection Control Business (2015-2020) (Million US$)
Table 102. Abott Recent Development
Table 103. Bayer Company Details
Table 104. Bayer Business Overview
Table 105. Bayer Product
Table 106. Bayer Revenue in Hospital Acquired Infection Control Business (2015-2020) (Million US$)
Table 107. Bayer Recent Development
Table 108. BD Company Details
Table 109. BD Business Overview
Table 110. BD Product
Table 111. BD Revenue in Hospital Acquired Infection Control Business (2015-2020) (Million US$)
Table 112. BD Recent Development
Table 113. Kimberly-Clark Business Overview
Table 114. Kimberly-Clark Product
Table 115. Kimberly-Clark Company Details
Table 116. Kimberly-Clark Revenue in Hospital Acquired Infection Control Business (2015-2020) (Million US$)
Table 117. Kimberly-Clark Recent Development
Table 118. Nordion Company Details
Table 119. Nordion Business Overview
Table 120. Nordion Product
Table 121. Nordion Revenue in Hospital Acquired Infection Control Business (2015-2020) (Million US$)
Table 122. Nordion Recent Development
Table 123. Cepheid Company Details
Table 124. Cepheid Business Overview
Table 125. Cepheid Product
Table 126. Cepheid Revenue in Hospital Acquired Infection Control Business (2015-2020) (Million US$)
Table 127. Cepheid Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital Acquired Infection Control Market Share by Type: 2020 VS 2026
Figure 2. Urinary Tract Infections Features
Figure 3. Blood Stream Infections Features
Figure 4. Surgical Site Infections Features
Figure 5. Hospital Acquired Pneumonia Features
Figure 6. Gastrointestinal Infections Features
Figure 7. Tuberculosis Features
Figure 8. Global Hospital Acquired Infection Control Market Share by Application: 2020 VS 2026
Figure 9. Air Case Studies
Figure 10. Water Case Studies
Figure 11. Physical Surfaces Case Studies
Figure 12. Skin disinfectants Case Studies
Figure 13. Sterilization Case Studies
Figure 14. Hospital Acquired Infection Control Report Years Considered
Figure 15. Global Hospital Acquired Infection Control Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Hospital Acquired Infection Control Market Share by Regions: 2020 VS 2026
Figure 17. Global Hospital Acquired Infection Control Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Hospital Acquired Infection Control Market Share by Players in 2019
Figure 20. Global Top Hospital Acquired Infection Control Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital Acquired Infection Control as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Hospital Acquired Infection Control Revenue in 2019
Figure 22. North America Hospital Acquired Infection Control Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Hospital Acquired Infection Control Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Hospital Acquired Infection Control Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Hospital Acquired Infection Control Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Hospital Acquired Infection Control Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Hospital Acquired Infection Control Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Hospital Acquired Infection Control Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Bottom-up and Top-down Approaches for This Report
Figure 30. Data Triangulation
Figure 31. Key Executives Interviewed
医療関連感染（HAI）診断の世界市場（～2026年） Patients may catch infections during they are in the hospital, the hospital acquired infection test is used to diagnose those infections. The industry is anticipated to witness a significant growth in the next few years. One of the key factors driving industry growth is the rising geriatric populati…- 医療関連感染（HAI）治療の世界市場（～2026年） Hospital Acquired Infection Treatment is an infection that is acquired in a hospital or other health care facility. Market Analysis and Insights: Global Hospital Acquired Infection Treatment Market The global Hospital Acquired Infection Treatment market size is projected to reach US$ 19430 million b…
- 院内感染治療の世界市場（～2026年） Hospital-acquired infections, also known as nosocomial infections, are acquired by patients in the hospitals or healthcare facilities. Urinary tract infections, bloodstream infections, surgical-site infections, Clostridium difficile associated diarrhea, and pneumonia are examples of nosocomial infec…
- 院内肺炎予防の世界市場（～2026年） HAP is defined as a lower respiratory infection, which does not incubate at the time of hospital admission but presents clinically 2 or more days after hospitalization.Incidence of HAP is more prevalent in the medical and surgical Intensive Care Units, and results in additional cost to the healthcar…
- 尿路感染症治療の世界市場（～2026年） Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasin…